Duloxetine Hydrochloride

盐酸度洛西汀

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameDuloxetine Hydrochloride
Drug Alias NameDuloxetina Hydrochloride盐酸度氯西汀Duloxetinum Hydrochloride盐酸度洛西丁盐酸度乐西汀 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDiabetic peripheral neuropathySolid tumoursStress Disorders, Post-Traumatic +[38] 
Global Approved IndicationsDepressive Disorder, MajorAnxiety DisordersDepression +[7] 
Approved Indications in ChinaDepression
Original Approved Country/TerritoryUnited States
Original Approved Date2004/08/03
Country/TerritoryCzechiaBelgiumCanada +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesCarlos Iii Health InstituteMansoura UniversityEli Lilly And Company +[11] 
Inactive CompaniesUtah State UniversityC.H. Boehringer Sohn Ag & Co. KgWeill Medical College of Cornell University +[17] 
Active IndicationsDiabetic peripheral neuropathySolid tumoursDepressive Disorder, Major +[16] 
Inactive IndicationsStress Disorders, Post-TraumaticDepressive DisorderAnxiety Disorders +[22] 

Other Information

ATC CodeN06AX21
Related LinksWikipediaDrugBankKEGG